nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—CYP2C9—Ifosfamide—germ cell cancer	0.129	0.507	CbGbCtD
Flecainide—CYP2C9—Cisplatin—germ cell cancer	0.0625	0.247	CbGbCtD
Flecainide—CYP2D6—Vinblastine—germ cell cancer	0.0624	0.246	CbGbCtD
Flecainide—CYP2C9—cardial valve—germ cell cancer	0.0102	0.445	CbGeAlD
Flecainide—CYP2C9—urine—germ cell cancer	0.00219	0.096	CbGeAlD
Flecainide—Renal failure—Etoposide—germ cell cancer	0.00201	0.00278	CcSEcCtD
Flecainide—Neuropathy peripheral—Etoposide—germ cell cancer	0.002	0.00277	CcSEcCtD
Flecainide—Coma—Methotrexate—germ cell cancer	0.002	0.00276	CcSEcCtD
Flecainide—Jaundice—Etoposide—germ cell cancer	0.00199	0.00275	CcSEcCtD
Flecainide—Discomfort—Bleomycin—germ cell cancer	0.00199	0.00275	CcSEcCtD
Flecainide—Malaise—Dactinomycin—germ cell cancer	0.00199	0.00275	CcSEcCtD
Flecainide—Decreased appetite—Vinblastine—germ cell cancer	0.00199	0.00275	CcSEcCtD
Flecainide—Urine output increased—Methotrexate—germ cell cancer	0.00198	0.00273	CcSEcCtD
Flecainide—Leukopenia—Dactinomycin—germ cell cancer	0.00198	0.00273	CcSEcCtD
Flecainide—Gynaecomastia—Methotrexate—germ cell cancer	0.00196	0.00271	CcSEcCtD
Flecainide—Constipation—Vinblastine—germ cell cancer	0.00196	0.0027	CcSEcCtD
Flecainide—Pain—Vinblastine—germ cell cancer	0.00196	0.0027	CcSEcCtD
Flecainide—Pulmonary oedema—Methotrexate—germ cell cancer	0.00195	0.00269	CcSEcCtD
Flecainide—Confusional state—Bleomycin—germ cell cancer	0.00195	0.00269	CcSEcCtD
Flecainide—Oedema—Bleomycin—germ cell cancer	0.00193	0.00267	CcSEcCtD
Flecainide—Visual impairment—Cisplatin—germ cell cancer	0.00193	0.00267	CcSEcCtD
Flecainide—Agranulocytosis—Etoposide—germ cell cancer	0.00191	0.00263	CcSEcCtD
Flecainide—Vision blurred—Ifosfamide—germ cell cancer	0.00191	0.00263	CcSEcCtD
Flecainide—Thrombocytopenia—Bleomycin—germ cell cancer	0.00189	0.00261	CcSEcCtD
Flecainide—Feeling abnormal—Vinblastine—germ cell cancer	0.00188	0.0026	CcSEcCtD
Flecainide—Myalgia—Dactinomycin—germ cell cancer	0.00188	0.0026	CcSEcCtD
Flecainide—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00188	0.00259	CcSEcCtD
Flecainide—Eye disorder—Cisplatin—germ cell cancer	0.00187	0.00259	CcSEcCtD
Flecainide—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00187	0.00258	CcSEcCtD
Flecainide—Tinnitus—Cisplatin—germ cell cancer	0.00187	0.00258	CcSEcCtD
Flecainide—Flushing—Cisplatin—germ cell cancer	0.00186	0.00257	CcSEcCtD
Flecainide—Discomfort—Dactinomycin—germ cell cancer	0.00186	0.00256	CcSEcCtD
Flecainide—Anorexia—Bleomycin—germ cell cancer	0.00184	0.00254	CcSEcCtD
Flecainide—Hypoaesthesia—Etoposide—germ cell cancer	0.00183	0.00252	CcSEcCtD
Flecainide—Malaise—Ifosfamide—germ cell cancer	0.00182	0.00252	CcSEcCtD
Flecainide—Vertigo—Ifosfamide—germ cell cancer	0.00182	0.00251	CcSEcCtD
Flecainide—Leukopenia—Ifosfamide—germ cell cancer	0.00181	0.0025	CcSEcCtD
Flecainide—Polyuria—Methotrexate—germ cell cancer	0.00181	0.0025	CcSEcCtD
Flecainide—Immune system disorder—Cisplatin—germ cell cancer	0.00181	0.0025	CcSEcCtD
Flecainide—Abdominal pain—Vinblastine—germ cell cancer	0.00181	0.0025	CcSEcCtD
Flecainide—Hypotension—Bleomycin—germ cell cancer	0.0018	0.00249	CcSEcCtD
Flecainide—Oedema—Dactinomycin—germ cell cancer	0.0018	0.00249	CcSEcCtD
Flecainide—Palpitations—Ifosfamide—germ cell cancer	0.00179	0.00247	CcSEcCtD
Flecainide—Alopecia—Cisplatin—germ cell cancer	0.00177	0.00244	CcSEcCtD
Flecainide—Hepatic failure—Methotrexate—germ cell cancer	0.00177	0.00244	CcSEcCtD
Flecainide—Cough—Ifosfamide—germ cell cancer	0.00176	0.00244	CcSEcCtD
Flecainide—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00176	0.00244	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00176	0.00243	CcSEcCtD
Flecainide—Convulsion—Ifosfamide—germ cell cancer	0.00175	0.00242	CcSEcCtD
Flecainide—Hypertension—Ifosfamide—germ cell cancer	0.00175	0.00241	CcSEcCtD
Flecainide—Paraesthesia—Bleomycin—germ cell cancer	0.00173	0.0024	CcSEcCtD
Flecainide—Dyspnoea—Bleomycin—germ cell cancer	0.00172	0.00238	CcSEcCtD
Flecainide—Myalgia—Ifosfamide—germ cell cancer	0.00172	0.00238	CcSEcCtD
Flecainide—Arthralgia—Ifosfamide—germ cell cancer	0.00172	0.00238	CcSEcCtD
Flecainide—Chest pain—Ifosfamide—germ cell cancer	0.00172	0.00238	CcSEcCtD
Flecainide—Flatulence—Cisplatin—germ cell cancer	0.00172	0.00237	CcSEcCtD
Flecainide—Anorexia—Dactinomycin—germ cell cancer	0.00172	0.00237	CcSEcCtD
Flecainide—Eye disorder—Etoposide—germ cell cancer	0.00171	0.00237	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00171	0.00236	CcSEcCtD
Flecainide—Flushing—Etoposide—germ cell cancer	0.0017	0.00235	CcSEcCtD
Flecainide—Discomfort—Ifosfamide—germ cell cancer	0.0017	0.00235	CcSEcCtD
Flecainide—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.00168	0.00233	CcSEcCtD
Flecainide—Decreased appetite—Bleomycin—germ cell cancer	0.00168	0.00232	CcSEcCtD
Flecainide—Visual disturbance—Methotrexate—germ cell cancer	0.00168	0.00232	CcSEcCtD
Flecainide—Confusional state—Ifosfamide—germ cell cancer	0.00166	0.0023	CcSEcCtD
Flecainide—Immune system disorder—Etoposide—germ cell cancer	0.00166	0.00229	CcSEcCtD
Flecainide—Pain—Bleomycin—germ cell cancer	0.00165	0.00228	CcSEcCtD
Flecainide—Oedema—Ifosfamide—germ cell cancer	0.00165	0.00228	CcSEcCtD
Flecainide—CYP2D6—urine—germ cell cancer	0.00165	0.072	CbGeAlD
Flecainide—Vision blurred—Cisplatin—germ cell cancer	0.00164	0.00227	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00164	0.00227	CcSEcCtD
Flecainide—Asthenia—Vinblastine—germ cell cancer	0.00164	0.00227	CcSEcCtD
Flecainide—Tremor—Cisplatin—germ cell cancer	0.00163	0.00226	CcSEcCtD
Flecainide—Alopecia—Etoposide—germ cell cancer	0.00162	0.00224	CcSEcCtD
Flecainide—Nervous system disorder—Ifosfamide—germ cell cancer	0.00162	0.00224	CcSEcCtD
Flecainide—Ill-defined disorder—Cisplatin—germ cell cancer	0.00162	0.00223	CcSEcCtD
Flecainide—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00162	0.00223	CcSEcCtD
Flecainide—Skin disorder—Ifosfamide—germ cell cancer	0.0016	0.00221	CcSEcCtD
Flecainide—Hyperhidrosis—Ifosfamide—germ cell cancer	0.0016	0.0022	CcSEcCtD
Flecainide—Feeling abnormal—Bleomycin—germ cell cancer	0.00159	0.0022	CcSEcCtD
Flecainide—Anorexia—Ifosfamide—germ cell cancer	0.00157	0.00217	CcSEcCtD
Flecainide—Malaise—Cisplatin—germ cell cancer	0.00157	0.00217	CcSEcCtD
Flecainide—Decreased appetite—Dactinomycin—germ cell cancer	0.00157	0.00216	CcSEcCtD
Flecainide—Diarrhoea—Vinblastine—germ cell cancer	0.00156	0.00216	CcSEcCtD
Flecainide—Dysgeusia—Etoposide—germ cell cancer	0.00156	0.00216	CcSEcCtD
Flecainide—Leukopenia—Cisplatin—germ cell cancer	0.00156	0.00216	CcSEcCtD
Flecainide—Fatigue—Dactinomycin—germ cell cancer	0.00155	0.00215	CcSEcCtD
Flecainide—Hypotension—Ifosfamide—germ cell cancer	0.00154	0.00213	CcSEcCtD
Flecainide—Pain—Dactinomycin—germ cell cancer	0.00154	0.00213	CcSEcCtD
Flecainide—Urticaria—Bleomycin—germ cell cancer	0.00153	0.00212	CcSEcCtD
Flecainide—Body temperature increased—Bleomycin—germ cell cancer	0.00153	0.00211	CcSEcCtD
Flecainide—Dizziness—Vinblastine—germ cell cancer	0.00151	0.00209	CcSEcCtD
Flecainide—Convulsion—Cisplatin—germ cell cancer	0.00151	0.00209	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.0015	0.00208	CcSEcCtD
Flecainide—Ataxia—Methotrexate—germ cell cancer	0.00149	0.00206	CcSEcCtD
Flecainide—Myalgia—Cisplatin—germ cell cancer	0.00148	0.00205	CcSEcCtD
Flecainide—Feeling abnormal—Dactinomycin—germ cell cancer	0.00148	0.00205	CcSEcCtD
Flecainide—Paraesthesia—Ifosfamide—germ cell cancer	0.00148	0.00205	CcSEcCtD
Flecainide—Ill-defined disorder—Etoposide—germ cell cancer	0.00148	0.00205	CcSEcCtD
Flecainide—Anxiety—Cisplatin—germ cell cancer	0.00148	0.00204	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00147	0.00204	CcSEcCtD
Flecainide—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00147	0.00203	CcSEcCtD
Flecainide—Dyspnoea—Ifosfamide—germ cell cancer	0.00147	0.00203	CcSEcCtD
Flecainide—Somnolence—Ifosfamide—germ cell cancer	0.00147	0.00203	CcSEcCtD
Flecainide—Discomfort—Cisplatin—germ cell cancer	0.00147	0.00203	CcSEcCtD
Flecainide—Vomiting—Vinblastine—germ cell cancer	0.00145	0.00201	CcSEcCtD
Flecainide—Malaise—Etoposide—germ cell cancer	0.00144	0.00199	CcSEcCtD
Flecainide—Vertigo—Etoposide—germ cell cancer	0.00143	0.00198	CcSEcCtD
Flecainide—Decreased appetite—Ifosfamide—germ cell cancer	0.00143	0.00198	CcSEcCtD
Flecainide—Headache—Vinblastine—germ cell cancer	0.00143	0.00198	CcSEcCtD
Flecainide—Leukopenia—Etoposide—germ cell cancer	0.00143	0.00198	CcSEcCtD
Flecainide—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00142	0.00197	CcSEcCtD
Flecainide—Abdominal pain—Dactinomycin—germ cell cancer	0.00142	0.00197	CcSEcCtD
Flecainide—Body temperature increased—Dactinomycin—germ cell cancer	0.00142	0.00197	CcSEcCtD
Flecainide—Fatigue—Ifosfamide—germ cell cancer	0.00142	0.00197	CcSEcCtD
Flecainide—Oedema—Cisplatin—germ cell cancer	0.00142	0.00197	CcSEcCtD
Flecainide—Pain—Ifosfamide—germ cell cancer	0.00141	0.00195	CcSEcCtD
Flecainide—Constipation—Ifosfamide—germ cell cancer	0.00141	0.00195	CcSEcCtD
Flecainide—Loss of consciousness—Etoposide—germ cell cancer	0.0014	0.00194	CcSEcCtD
Flecainide—Nervous system disorder—Cisplatin—germ cell cancer	0.0014	0.00193	CcSEcCtD
Flecainide—Cough—Etoposide—germ cell cancer	0.00139	0.00193	CcSEcCtD
Flecainide—Thrombocytopenia—Cisplatin—germ cell cancer	0.00139	0.00192	CcSEcCtD
Flecainide—Tachycardia—Cisplatin—germ cell cancer	0.00139	0.00192	CcSEcCtD
Flecainide—Asthenia—Bleomycin—germ cell cancer	0.00139	0.00191	CcSEcCtD
Flecainide—Convulsion—Etoposide—germ cell cancer	0.00138	0.00191	CcSEcCtD
Flecainide—Skin disorder—Cisplatin—germ cell cancer	0.00138	0.00191	CcSEcCtD
Flecainide—Hypertension—Etoposide—germ cell cancer	0.00138	0.00191	CcSEcCtD
Flecainide—Hyperhidrosis—Cisplatin—germ cell cancer	0.00138	0.0019	CcSEcCtD
Flecainide—Pruritus—Bleomycin—germ cell cancer	0.00137	0.00189	CcSEcCtD
Flecainide—Feeling abnormal—Ifosfamide—germ cell cancer	0.00136	0.00188	CcSEcCtD
Flecainide—Chest pain—Etoposide—germ cell cancer	0.00136	0.00188	CcSEcCtD
Flecainide—Nausea—Vinblastine—germ cell cancer	0.00136	0.00188	CcSEcCtD
Flecainide—Anorexia—Cisplatin—germ cell cancer	0.00136	0.00187	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00135	0.00187	CcSEcCtD
Flecainide—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00135	0.00186	CcSEcCtD
Flecainide—Discomfort—Etoposide—germ cell cancer	0.00134	0.00186	CcSEcCtD
Flecainide—Hypotension—Cisplatin—germ cell cancer	0.00133	0.00184	CcSEcCtD
Flecainide—Confusional state—Etoposide—germ cell cancer	0.00131	0.00182	CcSEcCtD
Flecainide—Urticaria—Ifosfamide—germ cell cancer	0.00131	0.00181	CcSEcCtD
Flecainide—Body temperature increased—Ifosfamide—germ cell cancer	0.0013	0.0018	CcSEcCtD
Flecainide—Abdominal pain—Ifosfamide—germ cell cancer	0.0013	0.0018	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.0013	0.00179	CcSEcCtD
Flecainide—Asthenia—Dactinomycin—germ cell cancer	0.00129	0.00179	CcSEcCtD
Flecainide—Dysuria—Methotrexate—germ cell cancer	0.00128	0.00177	CcSEcCtD
Flecainide—Paraesthesia—Cisplatin—germ cell cancer	0.00128	0.00177	CcSEcCtD
Flecainide—Thrombocytopenia—Etoposide—germ cell cancer	0.00128	0.00176	CcSEcCtD
Flecainide—Tachycardia—Etoposide—germ cell cancer	0.00127	0.00176	CcSEcCtD
Flecainide—Dyspnoea—Cisplatin—germ cell cancer	0.00127	0.00175	CcSEcCtD
Flecainide—Skin disorder—Etoposide—germ cell cancer	0.00127	0.00175	CcSEcCtD
Flecainide—Erectile dysfunction—Methotrexate—germ cell cancer	0.00126	0.00175	CcSEcCtD
Flecainide—Hyperhidrosis—Etoposide—germ cell cancer	0.00126	0.00174	CcSEcCtD
Flecainide—Photosensitivity reaction—Methotrexate—germ cell cancer	0.00125	0.00173	CcSEcCtD
Flecainide—Anorexia—Etoposide—germ cell cancer	0.00124	0.00172	CcSEcCtD
Flecainide—Decreased appetite—Cisplatin—germ cell cancer	0.00124	0.00171	CcSEcCtD
Flecainide—Diarrhoea—Dactinomycin—germ cell cancer	0.00123	0.0017	CcSEcCtD
Flecainide—Pneumonia—Methotrexate—germ cell cancer	0.00123	0.0017	CcSEcCtD
Flecainide—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00123	0.0017	CcSEcCtD
Flecainide—Vomiting—Bleomycin—germ cell cancer	0.00123	0.0017	CcSEcCtD
Flecainide—Hypotension—Etoposide—germ cell cancer	0.00122	0.00168	CcSEcCtD
Flecainide—Rash—Bleomycin—germ cell cancer	0.00122	0.00168	CcSEcCtD
Flecainide—Pain—Cisplatin—germ cell cancer	0.00122	0.00168	CcSEcCtD
Flecainide—Dermatitis—Bleomycin—germ cell cancer	0.00122	0.00168	CcSEcCtD
Flecainide—SCN4A—pituitary gland—germ cell cancer	0.00121	0.053	CbGeAlD
Flecainide—Renal failure—Methotrexate—germ cell cancer	0.0012	0.00166	CcSEcCtD
Flecainide—Asthenia—Ifosfamide—germ cell cancer	0.00118	0.00164	CcSEcCtD
Flecainide—Feeling abnormal—Cisplatin—germ cell cancer	0.00117	0.00162	CcSEcCtD
Flecainide—Paraesthesia—Etoposide—germ cell cancer	0.00117	0.00162	CcSEcCtD
Flecainide—Pruritus—Ifosfamide—germ cell cancer	0.00117	0.00161	CcSEcCtD
Flecainide—Haematuria—Methotrexate—germ cell cancer	0.00117	0.00161	CcSEcCtD
Flecainide—Dyspnoea—Etoposide—germ cell cancer	0.00116	0.00161	CcSEcCtD
Flecainide—Somnolence—Etoposide—germ cell cancer	0.00116	0.0016	CcSEcCtD
Flecainide—Nausea—Bleomycin—germ cell cancer	0.00115	0.00158	CcSEcCtD
Flecainide—Vomiting—Dactinomycin—germ cell cancer	0.00115	0.00158	CcSEcCtD
Flecainide—Agranulocytosis—Methotrexate—germ cell cancer	0.00114	0.00158	CcSEcCtD
Flecainide—Rash—Dactinomycin—germ cell cancer	0.00114	0.00157	CcSEcCtD
Flecainide—Decreased appetite—Etoposide—germ cell cancer	0.00113	0.00157	CcSEcCtD
Flecainide—Diarrhoea—Ifosfamide—germ cell cancer	0.00113	0.00156	CcSEcCtD
Flecainide—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00113	0.00155	CcSEcCtD
Flecainide—Body temperature increased—Cisplatin—germ cell cancer	0.00112	0.00155	CcSEcCtD
Flecainide—Fatigue—Etoposide—germ cell cancer	0.00112	0.00155	CcSEcCtD
Flecainide—Pain—Etoposide—germ cell cancer	0.00111	0.00154	CcSEcCtD
Flecainide—Constipation—Etoposide—germ cell cancer	0.00111	0.00154	CcSEcCtD
Flecainide—Dizziness—Ifosfamide—germ cell cancer	0.00109	0.00151	CcSEcCtD
Flecainide—SCN4A—adrenal gland—germ cell cancer	0.00108	0.0474	CbGeAlD
Flecainide—Feeling abnormal—Etoposide—germ cell cancer	0.00107	0.00148	CcSEcCtD
Flecainide—Nausea—Dactinomycin—germ cell cancer	0.00107	0.00148	CcSEcCtD
Flecainide—Gastrointestinal pain—Etoposide—germ cell cancer	0.00107	0.00147	CcSEcCtD
Flecainide—Visual impairment—Methotrexate—germ cell cancer	0.00106	0.00146	CcSEcCtD
Flecainide—Vomiting—Ifosfamide—germ cell cancer	0.00105	0.00145	CcSEcCtD
Flecainide—Rash—Ifosfamide—germ cell cancer	0.00104	0.00144	CcSEcCtD
Flecainide—Dermatitis—Ifosfamide—germ cell cancer	0.00104	0.00144	CcSEcCtD
Flecainide—Urticaria—Etoposide—germ cell cancer	0.00104	0.00143	CcSEcCtD
Flecainide—Abdominal pain—Etoposide—germ cell cancer	0.00103	0.00142	CcSEcCtD
Flecainide—Body temperature increased—Etoposide—germ cell cancer	0.00103	0.00142	CcSEcCtD
Flecainide—Eye disorder—Methotrexate—germ cell cancer	0.00103	0.00142	CcSEcCtD
Flecainide—Tinnitus—Methotrexate—germ cell cancer	0.00102	0.00142	CcSEcCtD
Flecainide—Asthenia—Cisplatin—germ cell cancer	0.00102	0.00141	CcSEcCtD
Flecainide—Immune system disorder—Methotrexate—germ cell cancer	0.000993	0.00137	CcSEcCtD
Flecainide—Nausea—Ifosfamide—germ cell cancer	0.00098	0.00135	CcSEcCtD
Flecainide—Diarrhoea—Cisplatin—germ cell cancer	0.000973	0.00134	CcSEcCtD
Flecainide—Alopecia—Methotrexate—germ cell cancer	0.000971	0.00134	CcSEcCtD
Flecainide—Dysgeusia—Methotrexate—germ cell cancer	0.000937	0.00129	CcSEcCtD
Flecainide—Asthenia—Etoposide—germ cell cancer	0.000935	0.00129	CcSEcCtD
Flecainide—SCN4A—head—germ cell cancer	0.000927	0.0405	CbGeAlD
Flecainide—Pruritus—Etoposide—germ cell cancer	0.000922	0.00127	CcSEcCtD
Flecainide—Vomiting—Cisplatin—germ cell cancer	0.000905	0.00125	CcSEcCtD
Flecainide—Vision blurred—Methotrexate—germ cell cancer	0.000902	0.00125	CcSEcCtD
Flecainide—Rash—Cisplatin—germ cell cancer	0.000897	0.00124	CcSEcCtD
Flecainide—Dermatitis—Cisplatin—germ cell cancer	0.000896	0.00124	CcSEcCtD
Flecainide—SCN4A—testis—germ cell cancer	0.000895	0.0392	CbGeAlD
Flecainide—Diarrhoea—Etoposide—germ cell cancer	0.000892	0.00123	CcSEcCtD
Flecainide—Ill-defined disorder—Methotrexate—germ cell cancer	0.000888	0.00123	CcSEcCtD
Flecainide—Malaise—Methotrexate—germ cell cancer	0.000863	0.00119	CcSEcCtD
Flecainide—Dizziness—Etoposide—germ cell cancer	0.000862	0.00119	CcSEcCtD
Flecainide—Vertigo—Methotrexate—germ cell cancer	0.000859	0.00119	CcSEcCtD
Flecainide—Leukopenia—Methotrexate—germ cell cancer	0.000856	0.00118	CcSEcCtD
Flecainide—Nausea—Cisplatin—germ cell cancer	0.000845	0.00117	CcSEcCtD
Flecainide—Cough—Methotrexate—germ cell cancer	0.000835	0.00115	CcSEcCtD
Flecainide—Convulsion—Methotrexate—germ cell cancer	0.000829	0.00115	CcSEcCtD
Flecainide—Vomiting—Etoposide—germ cell cancer	0.000829	0.00114	CcSEcCtD
Flecainide—Rash—Etoposide—germ cell cancer	0.000822	0.00114	CcSEcCtD
Flecainide—Dermatitis—Etoposide—germ cell cancer	0.000821	0.00113	CcSEcCtD
Flecainide—Headache—Etoposide—germ cell cancer	0.000817	0.00113	CcSEcCtD
Flecainide—Arthralgia—Methotrexate—germ cell cancer	0.000814	0.00113	CcSEcCtD
Flecainide—Chest pain—Methotrexate—germ cell cancer	0.000814	0.00113	CcSEcCtD
Flecainide—Myalgia—Methotrexate—germ cell cancer	0.000814	0.00113	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000809	0.00112	CcSEcCtD
Flecainide—Discomfort—Methotrexate—germ cell cancer	0.000805	0.00111	CcSEcCtD
Flecainide—Confusional state—Methotrexate—germ cell cancer	0.000787	0.00109	CcSEcCtD
Flecainide—Nausea—Etoposide—germ cell cancer	0.000774	0.00107	CcSEcCtD
Flecainide—Nervous system disorder—Methotrexate—germ cell cancer	0.000766	0.00106	CcSEcCtD
Flecainide—Thrombocytopenia—Methotrexate—germ cell cancer	0.000764	0.00106	CcSEcCtD
Flecainide—Skin disorder—Methotrexate—germ cell cancer	0.000758	0.00105	CcSEcCtD
Flecainide—Hyperhidrosis—Methotrexate—germ cell cancer	0.000755	0.00104	CcSEcCtD
Flecainide—Anorexia—Methotrexate—germ cell cancer	0.000744	0.00103	CcSEcCtD
Flecainide—Hypotension—Methotrexate—germ cell cancer	0.00073	0.00101	CcSEcCtD
Flecainide—SCN5A—head—germ cell cancer	0.000719	0.0314	CbGeAlD
Flecainide—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000711	0.000983	CcSEcCtD
Flecainide—Insomnia—Methotrexate—germ cell cancer	0.000706	0.000976	CcSEcCtD
Flecainide—Paraesthesia—Methotrexate—germ cell cancer	0.000701	0.000969	CcSEcCtD
Flecainide—Dyspnoea—Methotrexate—germ cell cancer	0.000696	0.000962	CcSEcCtD
Flecainide—Somnolence—Methotrexate—germ cell cancer	0.000694	0.000959	CcSEcCtD
Flecainide—Dyspepsia—Methotrexate—germ cell cancer	0.000687	0.000949	CcSEcCtD
Flecainide—Decreased appetite—Methotrexate—germ cell cancer	0.000679	0.000938	CcSEcCtD
Flecainide—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000674	0.000931	CcSEcCtD
Flecainide—Fatigue—Methotrexate—germ cell cancer	0.000673	0.00093	CcSEcCtD
Flecainide—SCN4A—brain—germ cell cancer	0.000672	0.0294	CbGeAlD
Flecainide—Pain—Methotrexate—germ cell cancer	0.000668	0.000922	CcSEcCtD
Flecainide—Feeling abnormal—Methotrexate—germ cell cancer	0.000643	0.000889	CcSEcCtD
Flecainide—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000638	0.000882	CcSEcCtD
Flecainide—Urticaria—Methotrexate—germ cell cancer	0.00062	0.000857	CcSEcCtD
Flecainide—Abdominal pain—Methotrexate—germ cell cancer	0.000617	0.000853	CcSEcCtD
Flecainide—Body temperature increased—Methotrexate—germ cell cancer	0.000617	0.000853	CcSEcCtD
Flecainide—Asthenia—Methotrexate—germ cell cancer	0.00056	0.000774	CcSEcCtD
Flecainide—Pruritus—Methotrexate—germ cell cancer	0.000552	0.000763	CcSEcCtD
Flecainide—Diarrhoea—Methotrexate—germ cell cancer	0.000534	0.000738	CcSEcCtD
Flecainide—SCN5A—brain—germ cell cancer	0.000521	0.0228	CbGeAlD
Flecainide—Dizziness—Methotrexate—germ cell cancer	0.000516	0.000713	CcSEcCtD
Flecainide—Vomiting—Methotrexate—germ cell cancer	0.000496	0.000686	CcSEcCtD
Flecainide—Rash—Methotrexate—germ cell cancer	0.000492	0.00068	CcSEcCtD
Flecainide—Dermatitis—Methotrexate—germ cell cancer	0.000492	0.000679	CcSEcCtD
Flecainide—Headache—Methotrexate—germ cell cancer	0.000489	0.000676	CcSEcCtD
Flecainide—CYP2D6—brainstem—germ cell cancer	0.000488	0.0213	CbGeAlD
Flecainide—Nausea—Methotrexate—germ cell cancer	0.000464	0.000641	CcSEcCtD
Flecainide—CYP2D6—telencephalon—germ cell cancer	0.000433	0.0189	CbGeAlD
Flecainide—CYP2C9—endocrine gland—germ cell cancer	0.000364	0.0159	CbGeAlD
Flecainide—CYP2D6—female gonad—germ cell cancer	0.000294	0.0128	CbGeAlD
Flecainide—CYP2D6—endocrine gland—germ cell cancer	0.000273	0.0119	CbGeAlD
Flecainide—CYP2D6—head—germ cell cancer	0.00027	0.0118	CbGeAlD
Flecainide—CYP2D6—testis—germ cell cancer	0.00026	0.0114	CbGeAlD
Flecainide—CYP2D6—cerebellum—germ cell cancer	0.00024	0.0105	CbGeAlD
Flecainide—CYP2D6—brain—germ cell cancer	0.000195	0.00855	CbGeAlD
